iris melanoma
Showing 1 - 25 of 2,731
Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)
Recruiting
- Metastatic Melanoma
- +9 more
- TBio-4101
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Stage IIA Uveal Melanoma Trial in Los Angeles (External Beam
Terminated
- Iris Melanoma
- +6 more
- External Beam Radiation Therapy
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 22, 2020
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in
Completed
- Ciliary Body and Choroid Melanoma, Medium/Large Size
- +5 more
- Cixutumumab
- Laboratory biomarker analysis
-
Philadelphia, Pennsylvania
- +1 more
Feb 5, 2020
Observational Study of Iris Tumors
Recruiting
- Iris Tumor
-
Portland, OregonOregon Health & Science University
Sep 22, 2022
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Uveal Melanoma Trial in Worldwide
Recruiting
- Uveal Melanoma
-
Boston, Massachusetts
- +14 more
Jun 28, 2022
Iris Melanoma, Medium/Large Size Posterior Uveal Melanoma, Mucosal Melanoma Trial in United States (Laboratory Biomarker
Completed
- Iris Melanoma
- +19 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +147 more
Jun 24, 2020
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in
Completed
- Ciliary Body and Choroid Melanoma, Medium/Large Size
- +3 more
- recombinant interferon alfa-2b
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Feb 11, 2019
BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma Trial in Czechia, Italy, Spain (Encorafenib + Binimetinib)
Not yet recruiting
- BRAF V600 Mutation
- +3 more
- Encorafenib + Binimetinib
-
Olomouc, Czechia
- +5 more
Sep 14, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Aphakia, Mydriasis Trial in Changzhou (Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage
Recruiting
- Aphakia
- Mydriasis
- Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage Pupilloplasty
-
Changzhou, Jiangsu, ChinaPreoperatively and 6 Months Postoperatively
Apr 12, 2023
Exudative Retinal Detachment and Uveal Melanoma Trial in Boston (Dexamethasone intravitreal implant)
Recruiting
- Exudative Retinal Detachment and Uveal Melanoma
- Dexamethasone intravitreal implant
-
Boston, Massachusettsi. Ocular Melanoma Center, Massachusetts Eye and Ear
Jul 23, 2021
Iris Color and Day-Night Changes in the Sympathovagal Ratio
Completed
- Iris Diseases
- Iris Color Measurement , LF/HF Measurement
- (no location specified)
Mar 7, 2023
Iris Depigmentation Trial in Sohag (Nd-YAG Laser for iris depigmentation)
Recruiting
- Iris Depigmentation
- Nd-YAG Laser for iris depigmentation
-
Sohag, EgyptElshimaa A.Mateen
Oct 22, 2023
Cataract Trial (IFIS sleeve)
Not yet recruiting
- Cataract
- IFIS sleeve
- (no location specified)
Sep 28, 2023
Blood Vessel Patterns in Small Choroidal Tumors
Active, not recruiting
- Small Posterior Choroidal Tumors
-
Portland, OregonOHSU Knight Cancer Institute
Sep 10, 2021
IRIS- DESyne X2 in the IRIS-DES Registry
Recruiting
- Coronary Stenosis
- +2 more
- DESyne X2
-
Incheon, Korea, Republic of
- +5 more
Dec 11, 2022
Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,
Completed
- Acral Lentiginous Malignant Melanoma
- +10 more
- cediranib maleate
-
Toronto, Ontario, CanadaPrincess Margaret Hospital Phase 2 Consortium
Jul 27, 2018
Uveal Melanoma, Metastatic Trial in Hospitalet de Llobregat (AloCelyvir)
Not yet recruiting
- Uveal Melanoma, Metastatic
- AloCelyvir
-
Hospitalet de Llobregat, Barcelona, SpainICO Hospitalet
Sep 8, 2021
Metastatic Melanoma Trial in Los Angeles (sunitinib malate, temozolomide)
Completed
- Metastatic Melanoma
- sunitinib malate
- temozolomide
-
Los Angeles, CaliforniaUniversity of California Los Angeles (UCLA)
Jul 30, 2020
Iris Cameras in Mucopolysaccharidoses
Not yet recruiting
- Mucopolysaccharidoses
- Imaging
-
Manchester, United KingdomManchester University NHS Foundation Trust
Aug 30, 2022
Iris Trial in Assiut (Immunohistochemistry analysis)
Not yet recruiting
- Iris
- Immunohistochemistry analysis
-
Assiut, EgyptHassan Lotfy
Jul 29, 2022
Astigmatism, Cataract Trial in New York (Femtosecond laser assisted cataract surgery with astigmatism management)
Not yet recruiting
- Astigmatism
- Cataract
- Femtosecond laser assisted cataract surgery with astigmatism management
-
New York, New YorkKenneth J Rosenthal, MD PC
Sep 29, 2022
Glaucoma Trial in Canada, United States (Sulcus tube placement, Anterior chamber (AC) tube placement)
Not yet recruiting
- Glaucoma
- Sulcus tube placement
- Anterior chamber (AC) tube placement
-
San Francisco, California
- +4 more
Jun 20, 2023